| 发明名称 |
Chimeric anti-CD20 antibody, rituxan, for use in the treatment of chronic lymphocytic leukemia |
| 摘要 |
<p>A method of treating hematologic malignancies associated with a high number of circulating tumor cells by the administration of a therapeutic chimeric anti-CD20 antibody. These malignancies include in particular B-prolymphocytic leukemia (B-PLL), chronic lymphocytic leukemia (CLL), and transformed non-Hodgkin's lymphoma.</p> |
| 申请公布号 |
EP1616572(B1) |
申请公布日期 |
2010.09.01 |
| 申请号 |
EP20050022104 |
申请日期 |
1999.11.09 |
| 申请人 |
BIOGEN IDEC INC. |
发明人 |
GRILLO-LOPEZ, ANTONIO, J.;WHITE, CHRISTINE, A. |
| 分类号 |
A61K39/395;A61K31/196;A61K31/573;A61K31/675;A61K31/7076;A61K38/19;A61K38/20;A61K38/21;A61P35/00;A61P35/02;C07K16/28;C23C2/02;C23C2/06;C23C2/30 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
